![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Roumier Christophe Cheok Meyling H
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.10, Iss.11, 2009-11, pp. : 1839-1851
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacogenomics of acute leukemia
By Ansari Marc Krajinovic Maja
Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Immunotherapy in acute myeloid leukemia
Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Immunotherapy of Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology, Vol. 2, Iss. 3, 2001-09 ,pp. :